Treating Opioid Dependence With Injectable Extended-Release Naltrexone (XR-NTX): Who Will Respond?

J Addict Med · 2015 · PMC4450918 · PMID 25901451

Europe PMC DOI

hedged sentence

0.1500

closest p · 3.0× alpha

0.1500

boldest claim

The sentences

approached significanceP < 0.15not close (p > 0.1)

Four other variables (HIV serostatus, SF-36 Mental Component, EQ-5D Health subscale, and baseline craving) yielded interaction terms that approached significance (0.05 < P < 0.15).

also in 8,237 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.